miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor

Martin Pichler; Elke Winter; Anna Lena Ress; Thomas Bauernhofer; Armin Gerger; Tobias Kiesslich; Sigurd Lax; Hellmut Samonigg; Gerald Hoefler

doi:10.1136/jclinpath-2013-201904

Article info

Original article

miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor

Authors

Martin Pichler Division of Oncology, Department of Internal Medicine, Medical University of Graz (MUG), Graz, Austria PubMed articles Google scholar articles
Elke Winter Institute of Pathology, Medical University of Graz (MUG), Graz, Austria PubMed articles Google scholar articles
Anna Lena Ress Division of Oncology, Department of Internal Medicine, Medical University of Graz (MUG), Graz, Austria PubMed articles Google scholar articles
Thomas Bauernhofer Division of Oncology, Department of Internal Medicine, Medical University of Graz (MUG), Graz, Austria PubMed articles Google scholar articles
Armin Gerger Division of Oncology, Department of Internal Medicine, Medical University of Graz (MUG), Graz, Austria PubMed articles Google scholar articles
Tobias Kiesslich Department of Internal Medicine I, Paracelsus Medical University/Salzburger Landeskliniken (SALK), Salzburg, Austria PubMed articles Google scholar articles
Sigurd Lax Department of Pathology, General Hospital Graz West, Graz, Austria PubMed articles Google scholar articles
Hellmut Samonigg Division of Oncology, Department of Internal Medicine, Medical University of Graz (MUG), Graz, Austria PubMed articles Google scholar articles
Gerald Hoefler Institute of Pathology, Medical University of Graz (MUG), Graz, Austria PubMed articles Google scholar articles

Correspondence to Dr Martin Pichler, Medical University of Graz (MUG), Division of Clinical Oncology, Auenbruggerplatz 15, Graz A-8036, Austria; martin.pichler{at}medunigraz.at

View Full Text

Citation

Pichler M, Winter E, Ress AL, et al

miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor

Journal of Clinical Pathology 2014;67:198-203.

Publication history

Received August 14, 2013
Revised September 4, 2013
Accepted September 6, 2013
First published October 4, 2013.

Online issue publication

October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password